Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Allergic Reactions02:06

Allergic Reactions

29.0K
Overview
29.0K
Hypersensitivities01:30

Hypersensitivities

1.1K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.1K
Allergic Drug Reactions01:27

Allergic Drug Reactions

1.0K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.0K
Cross-reactivity00:42

Cross-reactivity

31.5K
Overview
31.5K
Antibody Structure01:10

Antibody Structure

61.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
61.4K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Financial support scheme following a recognised occupational injury].

Ugeskrift for laeger·2026
Same author

Platelets accelerate endoplasmic reticulum stress and promote hepatic steatosis.

JHEP reports : innovation in hepatology·2026
Same author

Impedance Pneumography for Diagnosing and Monitoring Asthma in Young Children: A Systematic Review.

Children (Basel, Switzerland)·2026
Same author

Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.

Allergy·2026
Same author

Perfluoroalkyl substance exposure and risk of asthma at age 9 years.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2025
Same author

Healthcare Professional Survey on Complementary Feeding and Allergy Prevention in High- Versus Low-Risk Infants: An EAACI Task Force Report.

Allergy·2025

相关实验视频

Updated: Sep 18, 2025

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.3K

[对黄虫毒液过敏] 黄虫的毒液过敏

Hans-Jørgen Malling1, Kirsten Skamstrup Hansen1,2, Susanne Halken3

  • 1Klinik for Allergi, Hud- og Kønssygdomme, Københavns Universitetshospital - Herlev og Gentofte Hospital.

Ugeskrift for laeger
|June 20, 2025
PubMed
概括
此摘要是机器生成的。

毒液免疫疗法 (VIT) 建议用于确诊的昆虫过敏和严重反应或生活质量下降的个人. 对VIT的诊断应该仅限于合适的候选人,治疗通常持续五年.

更多相关视频

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.5K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

33.9K

相关实验视频

Last Updated: Sep 18, 2025

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
09:45

Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects

Published on: April 21, 2018

13.3K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.5K
Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses
10:25

Extraction of Venom and Venom Gland Microdissections from Spiders for Proteomic and Transcriptomic Analyses

Published on: November 3, 2014

33.9K

科学领域:

  • 过敏和免疫学 过敏和免疫学
  • 临床医学 临床医学
  • 毒理学 毒理学 毒理学

背景情况:

  • 昆虫的过敏性影响全球众多个体.
  • 系统性过敏反应对健康构成重大风险.
  • 毒液免疫疗法 (VIT) 是严重的昆虫过敏的主要治疗方法.

研究的目的:

  • 为VIT的诊断工作和治疗指示制定明确的指导方针.
  • 确定从VIT中获益最多的患者群体.
  • 提供关于VIT持续时间和应急准备的建议.

主要方法:

  • 对有关毒药免疫疗法的现有文献进行系统审查.
  • 分析临床试验数据和专家共识.
  • 对诊断标准和治疗结果的评估.

主要成果:

  • 对VIT的诊断应保留给已确认敏感化和全身反应或显著生活质量损害的患者.
  • 不建议对单症状疹进行VIT.
  • 建议VIT的持续时间为5年,并携带上腺素自喷器.

结论:

  • 对于特定的患者群体来说,VIT是一种有价值的治疗方法,这些患者有昆虫过敏.
  • 仔细选择患者对于有效和安全的VIT至关重要.
  • 长期遵守和应急准备是VIT管理的重要组成部分.